Searched for
PFIZER INDIA
Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...
- Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian equities saw a broad-based selloff on Friday, led by IT stocks, dragging benchmarks sharply lower. Nifty fell 1.14% and Sensex dropp...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Pfizer announces 12-week paternity leave policy for biological, adoptive fathers within workforceThe policy offers birthing and non-birthing fathers the flexibility to avail leaves over a period of two years. The minimum number of leave...
- Pfizer’s 1st drug development lab in Asia opens in ChennaiThe centre would develop and support products in global markets and Pfizer's manufacturing centres, worldwide. The facility is among 12 cen...
- Pradip Shah appointed Pfizer India chairmanPfizer India on Monday appointed Pradip Shah as the chairman of its board following the resignation of R A Shah on February 3. Announcing t...
- Pfizer seeks emergency use approval for its COVID vaccine in IndiaThe firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the ...
- Pfizer India hires Monsanto’s Alind Sharma as HR headPfizer India has hired Alind Sharma from Monsanto to head the human resources department at the drug maker as its senior director.
- Pfizer India to merge with WyethPfizer India on Saturday said the company will merge its Indian subsidiary Wyeth Ltd with itself.
- Pfizer growing above industry average: Kewal Handa, PfizerHopefully, with the Budget being very positive and hopefully with some reform measures announced, we will see some uptake and we will see h...
- Pfizer India takes National Pharmaceutical Pricing Authority to court over Benadryl price cutPfizer India Ltd has taken the drug price regulator to court for reducing the price of a popular cough syrup, Benadryl , a brand it no long...
- Pfizer: No immediate cure seen for short-term hiccupsPfizer India, the Indian arm of the US drug major Pfizer Inc, reported muted performance for the four months ended March 2011.
- Pfizer to continue recruitment drivePfizer India will hire an additional 200 people in the next few months and will continue to increase its headcount because it sees minimal ...
- J&J takes over Pfizer’s OTC unitThe acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...
- Pfizer India evaluates impact of deal with J&JPfizer India, a subsidiary of the global pharmaceutical major Pfizer Inc, on Monday said it was evaluating the impact of the sale of global...
Load More
